Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
Open Access
- 1 January 2016
- journal article
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 30 (3) , 197-202
Abstract
Biochemical or clinical changes of hyperandrogenism are important elements of polycystic ovary syndrome (PCOS). There is currently no consensus on the definition and diagnostic criteria of hyperandrogenism in PCOS. The aim of this study was to investigate the complex symptoms of hyperandrogenic disorders and the correlations between metabolism and hyperandrogenism in patients with PCOS from an outpatient reproductive medicine clinic in China. We conducted a case control study of 125 PCOS patients and 130 controls to evaluate differences in body mass index (BMI), total testosterone (TT), modified Ferriman-Gallwey hirsutism score, sex hormone binding globulin (SHBG), homeostasis model assessment-estimated insulin resistance (HOMA-IR) and free androgen index (FAI) between PCOS patients and controls and subgroups of PCOS. The prevalence of acne and hirsutism did not differ significantly between the hyperandrogenic and non-hyperandrogenic subgroup. Patients with signs of hyperandrogenism had significantly higher BMI (P < 0.05), but differences in TT, SHBG, FAI and waist/hip ratio were insignificant. The odds ratio of overweight was calculated for all PCOS patients. Our results suggest that PCOS patients with high BMI tend to have functional disorders of androgen excess; therefore, BMI may be a strong predictor of hyperandrogenism in PCOS.Keywords
This publication has 30 references indexed in Scilit:
- Androgen receptor gene polymorphism and polycystic ovary syndromeInternational Journal of Gynecology & Obstetrics, 2012
- Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional studyArthritis Research & Therapy, 2012
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteriaFertility and Sterility, 2010
- Dermatology of androgen-related disordersClinics in Dermatology, 2006
- Obesity and the polycystic ovary syndromeInternational Journal of Obesity, 2002
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- The effects of insulin on 3β-hydroxysteroid dehydrogenase expression in human luteinized granulosa cellsJournal of the Society for Gynecologic Investigation, 1995
- Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glandsJournal of Endocrinology, 1992
- Obesity and Polycystic Ovary SyndromeaAnnals of the New York Academy of Sciences, 1991